Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabienne Gug

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Prion|January 24, 2009
Antiprion drugs as chemical tools to uncover mechanisms of prion propagationDéborah Tribouillard, Fabienne Gug, Hervé Galons, et al.
Biotechnology Journal|January 17, 2007
Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatographyDamien Guiffant, Déborah Tribouillard, Fabienne Gug, et al.
Methods (San Diego, Calif.)|June 6, 2006
A yeast-based assay to isolate drugs active against mammalian prionsStéphane Bach, Déborah Tribouillard, Nicolas Talarek, et al.
Bioconjugate Chemistry|January 23, 2010
Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatographyFabienne Gug, Nassima Oumata, Déborah Tribouillard-Tanvier, et al.
Plos One|April 24, 2008
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prionsDéborah Tribouillard-Tanvier, Vincent Béringue, Nathalie Desban, et al.
Biotechnology Journal|August 8, 2006
Using budding yeast to screen for anti-prion drugsDéborah Tribouillard, Stéphane Bach, Fabienne Gug, et al.
Plos One|May 15, 2008
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugsDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Prion|January 24, 2009
Antiprion drugs as chemical tools to uncover mechanisms of prion propagationDéborah Tribouillard, Fabienne Gug, Hervé Galons, et al.
Biotechnology Journal|January 17, 2007
Identification of intracellular targets of small molecular weight chemical compounds using affinity chromatographyDamien Guiffant, Déborah Tribouillard, Fabienne Gug, et al.
Methods (San Diego, Calif.)|June 6, 2006
A yeast-based assay to isolate drugs active against mammalian prionsStéphane Bach, Déborah Tribouillard, Nicolas Talarek, et al.
Bioconjugate Chemistry|January 23, 2010
Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatographyFabienne Gug, Nassima Oumata, Déborah Tribouillard-Tanvier, et al.
Plos One|April 24, 2008
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prionsDéborah Tribouillard-Tanvier, Vincent Béringue, Nathalie Desban, et al.
Biotechnology Journal|August 8, 2006
Using budding yeast to screen for anti-prion drugsDéborah Tribouillard, Stéphane Bach, Fabienne Gug, et al.
Plos One|May 15, 2008
Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugsDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, et al.
Pageof 1